TacticaMente S.A.C Competitors

Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies that are driving transformative change in their industries. As of December 31, 2025, the firm has over $90B in regulatory assets under management. Insight Partners has invested in more than 900 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Headquartered in New York City, Insight has a global presence with leadership in London, Tel Aviv, and the Bay Area. Insight’s mission is to find, fund, and work successfully with visionary executives, providing them with tailored, hands-on software expertise along their growth journey, from their first investment to IPO. For more information on Insight and all its investments, visit insightpartners.com or follow us on X @insightpartners.

【康至德】將前沿研究成果轉化為腦退化症的風險預測、診斷和疾病監測工具，利用血液在症狀出現階段之前檢測出認知障礙症。 At Cognitact, we are translating cutting-edge research efforts into a risk prediction, diagnostic and disease monitoring tool for dementia, aiming to detect Alzheimer's disease before its symptomatic stage using blood.

For over a decade, NeuroInsights has been helping entrepreneurs, executives, investors, and governments understand and profit from the growth of drugs, devices and diagnostics for the brain and nervous system. We achieve this through a broad range of strategic business advisory services, in-depth market and industry investment reports, Neurotech Insights - our monthly industry newsletter covering financing and product news, and our flagship neurotech investing and partnering conferences. Advisory services for investors, start-ups and corporations include: Due Diligence: Assessment of a specific company's competitive advantage, market opportunity, product pipeline, intellectual property, and exit strategy potential to minimize investment risk Start-up Acceleration: Proven methodologies to clarify value propositions and develop a realistic product strategy, revenue model, and business plan to accelerate fundraising process and create a solid foundation for success Product Licensing and Partnering: Find partners for inlicensing and outlicensing of products utilizing our extensive network of big pharma, biotech, start-ups and niche players Targeted Fundraising: Make the most of each investor meeting by optimizing corporate presentations and leveraging our extensive network of private and public investors Technology and Market Assessments: Evaluate your pipeline for strengths and weaknesses then expand your business through in-licensing, out-licensing, or strategic partnerships On-site Briefings: Comprehensive interactive seminars on neurotechnology companies, pipelines and technologies to keep your team and customers abreast of trends shaping the market and improve your strategic planning process Custom Research: In-depth answers to company, market, or technology specific questions tailored to your needs.